Chemotherapeutic efficacy of poly (dl-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis

This publication has 15 references indexed in Scilit:

• Chemotherapeutic Potential of Orally Administered Poly(Lactide-Co-Glycolide) Microparticles Containing Isoniazid, Rifampin, and Pyrazinamide against Experimental Tuberculosis
  Antimicrobial Agents and Chemotherapy, 2003
• Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis
  Tuberculosis, 2003
• Risk of tuberculosis among healthcare workers: can tuberculosis be considered as an occupational disease?
  Respiratory Medicine, 2002
• Role of poly [dl-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s)
  International Journal of Pharmaceutics, 2002
• A world-wide internet survey of public knowledge about tuberculosis
  Respiratory Medicine, 2002
• Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles
  Journal of Antimicrobial Chemotherapy, 2001
• Therapeutic Efficacy of Poly( dl -Lactide-Co-Glycolide)-Encapsulated Antitubercular Drugs against Mycobacterium tuberculosis Infection Induced in Mice
  Antimicrobial Agents and Chemotherapy, 2001
• Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification
  International Journal of Pharmaceutics, 1999
• Biodegradation and biocompatibility of PLA and PLGA microspheres
  Published by Elsevier ,1999
• Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice
  Antimicrobial Agents and Chemotherapy, 1989